Advertisement
News
Advertisement

PAREXEL Experts to Present Advanced Approaches to Accelerate Development, Maximize Product Value at DIA EuroMeeting

Mon, 03/07/2011 - 2:34am
Bio-Medicine.Org

BOSTON, March 7, 2011 /PRNewswire/ -- Through various presentations to be delivered at the Drug Information Association (DIA) 23rd Annual EuroMeeting, being held March 28-30, 2011 in Geneva, Switzerland, experts from PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, will address advanced approaches to help the biopharmaceutical industry meet demands of a changing global marketplace.

Experts from PAREXEL will be available at Stands 1050, 1052, 1151, and 1153 in the exhibit hall to discuss how the Company can help biopharmaceutical companies improve early-stage decisions, accelerate pivotal trials, reach new markets, and leverage technologies for increased operational quality and efficiency.  PAREXEL experts will discuss new operational models, supported by technology, to help its clients achieve greater benefits and speed development.

The DIA EuroMeeting program features the following presentations by PAREXEL experts, which address the benefits of combined clinical and technology expertise to enable more effective information flow and improved data access for greater visibility into trials – and ultimately, better decision making:

Tuesday, March 29

Session 1, 9:00: Use of Electronic Health Records for Clinical Research, Isabelle de Zegher, Worldwide Senior Director Technology Integration and Data Standards

Wednesday, March 30

Session 5, 9:00: How to Go Effectively from Data Collection in CDASH to Submission in SDTM: The need for an eCRF library, Isabelle de Zegher, Worldwide Senior Director Technology Integration & Data StandardsSession 6, 11:00: Using Technology to Improve the Clinical Trial Process, Liz Love, Product ManagerSession 8, 16:00: Simplicity (for sites) is the Ultim

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading